CSTM Forensic Analysis

PART 1: TRADING EXECUTION

Trading Setup & Entry Strategy

Constellium (CSTM) is currently exhibiting a parabolic momentum breakout fueled by massive fundamental catalysts (a massive Q1 earnings beat, FY26 guidance raise, and a multi-year Airbus supply agreement). However, trading at $32.95, the stock is overextended, sitting +20.4% above its 50-day SMA ($27.37) and piercing the upper Bollinger Band ($32.63).

Action Plan: DO NOT CHASE the gap-up blindly. We want asymmetry. The fundamental thesis is incredibly strong, meaning this is a core LONG, but we must exercise entry discipline to avoid localized drawdowns.

• •Entry Zone 1 (30% position): $31.86 (Current 5-Day SMA, acting as immediate short-term momentum support).
• •Entry Zone 2 (40% position): $30.00 (Psychological round number and prior resistance turned support).
• •Entry Zone 3 (30% position): $28.50 (Near the lower Bollinger Band and approaching the rising 50-day SMA, aggressive dip-buying zone).
• •Stop Loss: $26.80 (HARD STOP below the 50-day SMA of $27.37 to protect against a structural breakdown).
• •Take Profit Targets: Scale out 50% at $38.00, 30% at $42.00, and leave a 20% runner.
• •Position Sizing: 3-5% of total portfolio (high conviction, but volatile).
• •Risk/Reward: Blended entry around $30.00, Stop at $26.80 (Risk $3.20), Target $38.00 (Reward $8.00) = 1:2.5 R/R.

Executive Summary

Constellium SE is demonstrating immense operational leverage, highlighted by a blowout Q1 2026 featuring a 415% YoY increase in Net Income ($196M vs $38M) and a 93% YoY jump in Total Adjusted EBITDA ($359M vs $186M). The recent multi-year Airbus contract and a new $300M share repurchase authorization provide a concrete structural tailwind. While technicals are stretched following a 21.5% 20-day run, the low fundamental valuation (run-rate EV/EBITDA ~6x) and robust aerospace/packaging demand create a compelling Techno-Fundamental BUY on any consolidation.

---

PART 2: DETAILED RESEARCH

Recent Material Events (8-K Analysis)

• •March 12, 2026: Board of Directors authorized a new $300M share repurchase program expiring December 31, 2028, effectively replacing the 2024 program. This represents ~6.5% of the current market cap.
• •April 29, 2026: Q1 2026 Earnings release. The company crushed estimates and raised its full-year 2026 guidance, citing strong demand in aerospace and automotive supply shortages playing to their advantage.

Insider Trading Activity

Recent Form 4 filings logged between May 1 and May 5, 2026, indicate heavy administrative and executive transaction activity following the earnings blackout period lift. While much of this relates to the vesting of RSUs and PSUs, the retention of shares by key executives post-vesting amidst a parabolic rally is a subtle signal of internal confidence in the revised guidance.

Current News & Market Context

• •Catalyst 1 (April 21): CSTM secured a highly lucrative, multi-year deal with Airbus. This is a game-changer that guarantees long-term volume visibility for the Aerospace & Transportation (A&T) segment.
• •Catalyst 2 (April 29): Earnings blowout and guidance raise. Q1 results systematically destroyed consensus, driven by a 152% EBITDA surge in the P&ARP segment and an 18% volume increase in A&T.
• •Market Context: Supply chain shortages in North American automotive rolled products are allowing CSTM to capture market share and assert immense pricing power.

Business Model Analysis

Constellium operates on a "pass-through" business model where the underlying LME aluminum price and regional premiums are largely passed to the customer, isolating the company's profitability to its conversion margin and volume throughput.

• •Revenue Mix: P&ARP (60%), A&T (25%), AS&I (17%).
• •Pricing Power: Evidenced by Q1 results; despite total shipment volumes dropping slightly (-1% YoY to 370kt), revenue jumped 24% and Segment EBITDA surged 78%, proving CSTM can command premium conversion margins in supply-constrained environments.

Financial Health

CSTM's balance sheet and cash flow generation are structurally sound, though working capital intensive.

• •Liquidity: $143M in cash and cash equivalents, backed by $491M available on the Pan-U.S. ABL.
• •Debt: $1.93B in long-term debt. Leverage is decreasing rapidly due to the massive expansion in EBITDA.
• •Cash Flow: Q1 generated $73M in operating cash flow, easily covering $68M in CapEx. Q1 is historically a working-capital-heavy quarter (inventory build), making positive OCF highly impressive.

Valuation Analysis

• •Implied Multiples: With Q1 Segment Adjusted EBITDA at $262M (excluding the $97M non-cash metal price lag), annualized operational EBITDA is roughly $1.05B. At a current Enterprise Value of ~$6.4B (Market Cap $4.48B + Net Debt $1.8B), CSTM trades at a highly attractive ~6.1x EV/EBITDA.
• •Reverse DCF: Current pricing implies a terminal growth rate of barely 1-2%, which severely undervalues the multi-year Airbus contract and secular lightweighting trends in automotive.

Competitive Position

CSTM holds a dominant duopoly/triopoly position in aerospace aluminum plate and auto body sheet. High barriers to entry (capital intensity, specialized metallurgy, rigorous aerospace certification) protect CSTM's moat. The Airbus deal explicitly confirms their top-tier supplier status.

Management Quality

Management is executing flawlessly. CEO Ingrid Joerg has successfully navigated European energy volatility and inflation. More importantly, capital allocation is shareholder-friendly: they actively bought back 1.15M shares in Q1 for $28M at an average price of $24.34—a brilliant capital allocation move given the current $32.95 price.

Risk Factors

• •Cyclicality (Medium): Auto and packaging demand can fluctuate with global recessions.
• •Working Capital Swings (Medium): A sudden drop in aluminum prices can cause short-term inventory valuation pain, though the pass-through model mitigates long-term impact.
• •European Energy Exposure (Low/Medium): While hedged, heavy reliance on European manufacturing exposes them to regional energy shocks.

Forensic Accounting Flags

• •⚠️ Factoring Reliance: CSTM has $430M of receivables derecognized through off-balance-sheet factoring arrangements. While standard for the industry, it flatters operating cash flow.
• •⚠️ Metal Price Lag: Q1 Adjusted EBITDA of $359M included a $97M positive adjustment for "metal price lag" (a non-cash timing difference). True operational EBITDA is $262M. We must value them on the $262M to avoid cyclical value traps.
• •✅ SBC/Dilution: Very clean. Only $11M in SBC for Q1, and buybacks far outpace dilution.

Technical Analysis & Trade Timing

The technical setup is a classic BULLISH_UPTREND experiencing momentum climax.

• •RSI (14): 65.69 (Approaching overbought, suggesting a cooling-off period is imminent).
• •Moving Averages: The 50-day SMA ($27.37) recently crossed aggressively upward, but the price is stretched +20.4% above it.
• •Bollinger Bands: Price is piercing the upper band ($32.63), a clear sign of near-term FOMO.
• •Reconciliation: The fundamentals justify a much higher valuation, but the technicals dictate patience. Buying a stock 20% above its 50-day moving average often leads to "shakeout" drawdowns. We will execute a "WAIT FOR PULLBACK" scaling strategy to marry the bullish fundamentals with safe technical entries.

Short-Term Trading Strategy (2-5 Days)

• •Recommended Timeframe: SWING_2_5_DAYS
• •Position Sizing: 3% of portfolio.
• •Scaling Strategy:
  • •Enter 30% at $31.80 (5-day SMA mean reversion).
  • •Add 40% at $30.00 (gap fill / psychological support).
  • •Final 30% at $28.50 (lower band / trendline support).
• •Risk/Reward: 1:2.5 R/R.
• •Max Hold Time: 14 days (allow the post-earnings momentum to digest and form a flag).
• •Catalyst Timing: Post-earnings drift phase. Enter on low-volume intraday pullbacks.
• •Stop Loss: HARD stop at $26.80 (below 50-day SMA).

Short Thesis

N/A - Fundamentals are too strong and technical momentum is parabolic. Shorting here violates the "Widowmaker" rule. If forced to hedge, buy out-of-the-money put options (e.g., $28 strikes) to define risk rather than shorting common stock.

Catalysts & Timeline

• •Immediate: Post-earnings analyst upgrades over the next 1-2 weeks.
• •Mid-term: Execution of the $300M buyback program will provide a continuous bid under the stock.
• •Long-term: Q2 2026 earnings (late July) to confirm the margin sustainability of the P&ARP segment.

Price Targets

Investment Recommendation

STRONG BUY (WITH PULLBACK ENTRY). Constellium has completely transformed its margin profile, validated by the massive Q1 beat and the Airbus contract. However, we must respect the 20%+ run over the last 20 days. Use disciplined scaling into the $30-$31 zone to capture asymmetrical upside toward $40+.

One-Liner Thesis: Constellium's structural margin transformation and massive Airbus contract represent a generational fundamental breakout, offering a high-conviction buy opportunity on any technical momentum pullback.